Transverse myelitis caused by hepatitis E: Previously undescribed in adults

BMJ Case Reports

Volumn 2015, Issue , 2015, Pages

  Sarkar, Pamela ^a   Morgan, Catherine ^a   Ijaz, Samreen ^b  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CEFTRIAXONE; HEPATITIS E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; METHYLPREDNISOLONE; PREDNISOLONE; ANTIINFLAMMATORY AGENT; BIOLOGICAL MARKER;

ACUTE DISEASE; ADULT; ANUS SPHINCTER DISORDER; ARTICLE; CASE REPORT; CAUCASIAN; CAUDA EQUINA; CEREBROSPINAL FLUID ANALYSIS; CLINICAL EXAMINATION; FEMALE; HEADACHE; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; HUMAN CELL; LEG DISEASE; LEUKOCYTE COUNT; LIVER DYSFUNCTION; LIVER FUNCTION TEST; MALAISE; MYELITIS; NEUROLOGIC DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; PHYSIOTHERAPY; PRIORITY JOURNAL; REFLEX DISORDER; SPINAL CORD COMPRESSION; SPINE RADIOGRAPHY; URINE RETENTION; VIRUS DETECTION; BLOOD; COMPLICATION; DRUG PULSE THERAPY; LOWER LIMB; MIDDLE AGED; MYELITIS, TRANSVERSE; TREATMENT OUTCOME; URINARY RETENTION; VIROLOGY;

ANTI-INFLAMMATORY AGENTS; BIOMARKERS; FEMALE; HEPATITIS E; HUMANS; LOWER EXTREMITY; MAGNETIC RESONANCE IMAGING; METHYLPREDNISOLONE; MIDDLE AGED; MYELITIS, TRANSVERSE; PARESTHESIA; PHYSICAL THERAPY MODALITIES; PULSE THERAPY, DRUG; TREATMENT OUTCOME; URINARY RETENTION;

EID: 84938917223     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2014-209031     Document Type: Article

References (20)

1. Kamar N, Bendall R, Legrand-Abravanel F, et al. Hepatitis E. Lancet 2012;379:2477-88.
2. https://www.gov.uk/government/uploads/system/uploads/attachment-data/file/404107/hpr0515-zoos.pdf Health Protection Report Vol. 9 No. 5-13 February 2015 (accessed 10 Mar 2015).
3. Dalton H, Bendall R, Ijaz S, et al. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 2008;8:698-709.
4. Ijaz S, Said B, Gajraj R, et al. Public health operational guidelines for hepatitis E Health protection response to reports of hepatitis E infection. Published January 2015, Page: 9. https://www.gov.uk/government/uploads/system/uploads/attachment-data/file/396909/PH-Operational-Guidelines-for-HepE-051214-Standard-template-CT.pdf
5. Kamar N, Izopet J, Cintas P, et al. Hepatitis E virus-induced neurological symptoms in a kidney-transplant patient with chronic hepatitis. Am J Transplant 2010;10:1321-4.
6. Ali G, Kumar M, Bali SK, et al. Hepatitis E associated immune thrombocytopenia and membranous glomerulonephritis. Indian J Nephrol 2001;11:70-2.
7. Deniel C, Coton T, Brardjanian S, et al. Acute pancreatitis: a rare complication of acute hepatitis E. J Clin Virol 2011;51:202-4.
8. Fourquet E, Mansuy JM, Bureau C, et al. Severe thrombocytopenia associated with acute autochthonous hepatitis E. J Clin Virol 2011;48:73-4.
9. Kejariwal D, Roy S, Sarkar N. Seizure associated with acute hepatitis E. Neurology 2001;57:1935.
10. Rianthavorn P, Thongmee C, Limpaphayom N, et al. The entire genome sequence of hepatitis E virus genotype 3 isolated from a patient with neuralgic amyotrophy. Scand J Infect Dis 2010;42:395-400.
11. Fong F, Illahi M. Neuralgic amyotrophy associated with hepatitis E virus. Clin Neurol Neurosurg 2009;111:193-5.
12. Loly JP, Rikir E, Seivert M, et al. Guillain-Barré syndrome following hepatitis E. World J Gastroenterol 2009;15:1645-7.
13. Sood A, Midha V, Sood N. Guillain-Barré syndrome with acute hepatitis E. Am J Gastroenterol 2000;95:3667-8.
14. Kamani P, Baijal R, Amarapurkar D, et al. Guillain-Barre syndrome associated with acute hepatitis E. Indian J Gastroenterol 2004;24:216.
15. Aktipi KM, Ravaglia S, Ceroni M, et al. Severe recurrent myelitis in patients with hepatitis C virus infection. Neurology 2007;68:468-9.
16. Trevisani F, Gattinara GC, Caraceni P, et al. Transverse myelitis following hepatitis B vaccination. J Hepatol 1993;19:317-18.
17. Tyler KL, Gross RA, Cascino GD. Unusual viral causes of transverse myelitis: hepatitis A virus and cytomegalovirus. Neurology 1986;36:855-8.
18. Stübgen JP. Immune-mediated myelitis associated with hepatitis virus infections. J Neuroimmunol 2011;239:21-7.
19. Mandal K, Chopra N. Acute transverse myelitis following hepatitis E virus infection. Indian Pediatr 2006;43:365-6.
20. Gerolami R, Borentain P, Raissouni F, et al. Treatment of severe acute hepatitis E by ribavirin. J Clin Virol 2011;52:60-2.